Posted on 01/25/2023 6:18:13 AM PST by buckalfa
Researchers at Palo Alto, Calif.-based Stanford Medicine have developed a Theranos-like test that screens for health measures using a single drop of blood.
The approach, relayed in a Jan. 19 study in Nature Biomedical Engineering, combines a finger-prick device with multiomics technologies that assess a variety of proteins, fats, metabolism byproducts, and inflammatory markers.
"Even more importantly, we've shown you can collect the blood drop at home and mail it into the lab," said Michael Snyder, PhD, director of the Stanford Center for Genomics and Personalized Medicine and senior author of the study, in a Jan. 19 university news release.
While not naming Theranos, which famously claimed to have revolutionized blood testing before its leaders were convicted of fraud, the release noted that the "research sounds similar to a well-known approach promoted in the past for testing a single drop of blood." However, this technique employs mass spectrometry molecule-sorting technology rather than replicating existing diagnostic tests, and the data analysis is done in a lab instead of a portable box.
The problem these days is that scientists will fudge results to keep grant money flowing.
The trust is gone.
Interesting in the fact that the former Theranos HQ in Palo Alto is now Stanford building.
former Theranos HQ in Palo Alto is now Stanford building.
So someone left documents in a closet?
Since it might lead to prevention of diseases the globalists do not want prevented, I expect it will go nowhere.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.